Clinical Trial Update: A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial comparing FLT-PET with FDG-PET/CT for early chemotherapy response assessment in resectable stage IB-IIIA non-small cell lung cancer; results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• FDG (fluorodeoxyglucose)
• FLT (3'-deoxy-3'-[18F]fluorothymidine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2017-03-17